Li-Nong Ji (Linong Ji, Ji Linong)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 55

Top Topics

Randomized Controlled Trial

Top Venues

Diabetes, obesity & metabolism

Journal of clinical hypertension (Greenwich, Conn.)

Journal of diabetes

Journal of diabetes science and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Nong Ji, Yi-Ming Mu, Cuiqing Chang, Huali Wang, Di Zhao, Dongmei Liu, Zewei Shen, Wei Chen
Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China study. Diabetes, obesity & metabolism (2024)
Li-Nong Ji
Current challenges of diabetes and metabolic disorders in China. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Jinmiao Lu, Leili Gao, Changjiang Ying, Jiao Sun, Jie Han, Wenhua Zhao, Yunming Gao, Kun Wang, Xin Zheng, Daosheng Xie, Juping Ding, Jiahong Zhao, Qiang Yu, Tong Wang
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Xiao-Fei Ye, Chao-Ying Miao, Wei Zhang, Li-Nong Ji, Ji-Gwang Wang, null null
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry. Journal of clinical hypertension (Greenwich, Conn.) 25 (2) (2023)
Chu Lin, Xingyun Zhu, Ruoyang Jiao, Xiaoling Cai, Suiyuan Hu, Fang Lv, Wenjia Yang, Zonglin Li, Li-Nong Ji
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: an analysis using national cross-sectional data. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Xiaozhen Jiang, Qingshun Hao, Zhifeng Cheng, Kun Wang, Shuguang Pang, Meiying Liu, Yushan Guo, Xiaowen Chen, Xiuhai Su, Tao Ning, Jie Liu, Fang Bian, Yulan Li, Zhinong Zhang, Weihong Song, Jingfang Sun
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trial. Diabetes, obesity & metabolism (2023)
Vanita R Aroda, Juan Pablo Frias, Li-Nong Ji, Elisabeth Niemoeller, My-Liên Nguyên-Pascal, Karl Denkel, Melanie Espinasse, Hailing Guo, SeungJae Baek, JaeDuk Choi, Ildiko Lingvay
Efficacy and Safety of Once-Weekly Efpeglenatide in People with Suboptimally Controlled Type 2 Diabetes: The AMPLITUDE-D, AMPLITUDE-L and AMPLITUDE-S Randomised Controlled Trials. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, A J Ahmann, Bo Ahrén, M S Capehorn, P Hu, Ildiko Lingvay, W Liu, Helena W Rodbard, Z Shen, C Sorli
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Li-Nong Ji, Xiaozhen Jiang, Qingshun Hao, Zhifeng Cheng, Kun Wang, Shuguang Pang, Meiying Liu, Yushan Guo, Xiaowen Chen, Xiuhai Su, Tao Ning, Jie Liu, Fang Bian, Yulan Li, Zhinong Zhang, Weihong Song, Jingfang Sun
Efficacy and Safety of Janagliflozin Monotherapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Diet and Exercise: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Trial. Diabetes, obesity & metabolism (2023)
Brenda W C Bongaerts, Oliver Kuß, Fabrice Bonnet, Hungta Chen, Andrew Cooper, Peter Fenici, Marília Brito Gomes, Niklas Hammar, Li-Nong Ji, Kamlesh Khunti F MedSci, Jesus Medina, Antonio Nicolucci, Marina V Shestakova, Hirotaka Watada, Wolfgang Rathmann
HbA 1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Yibin Lu, Qi Fu Li, Liujun Fu, Yong Luo, Tao Lei, Ling Li, Shandong Ye, Bimin Shi, Xiyan Li, Thomas Meinicke
Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A Phase III, randomised, double-blind, placebo-controlled, parallel study. Diabetes, obesity & metabolism (2023)
Xiao-Fei Ye, Chao-Ying Miao, Wei Zhang, Li-Nong Ji, Ji-Gwang Wang, null null
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry. Journal of clinical hypertension (Greenwich, Conn.) (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Matthias Blüher, Mohini Aras, Louis J Aronne, Rachel L Batterham, Francesco Giorgino, Li-Nong Ji, Kirsi H Pietiläinen, Oliver Schnell, Elena Tonchevska, John P H Wilding
New insights into the treatment of obesity. Diabetes, obesity & metabolism (2023)
Xiao-Fei Ye, Chao-Ying Miao, Wei Zhang, Li-Nong Ji, Ji-Gwang Wang, null null
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry. Journal of clinical hypertension (Greenwich, Conn.) 25 (2) (2023)
Xiao-Fei Ye, Chao-Ying Miao, Wei Zhang, Li-Nong Ji, Ji-Gwang Wang, null null
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry. Journal of clinical hypertension (Greenwich, Conn.) 25 (2) (2023)
Yingying Luo, Jun Xia, Zhan Zhao, Yaping Chang, Yong Mong Bee, Khue Thy Nguyen, Soo Lim, Daisuke Yabe, Margaret McGill, Alice Pik-Shan Kong, Siew Pheng Chan, Marisa Deodat, Chaicharn Deerochanawong, Ketut Suastika, Chenchen Xu, Liming Chen, Wei Chen, Xiaoying Li, Weigang Zhao, Xiaomei Yao, Li-Nong Ji
Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysis. Journal of diabetes (2023)
Stephen Twigg, Soo Lim, Seung-Hyun Yoo, Liming Chen, Yuqian Bao, Alice Pik-Shan Kong, Ester Yeoh, Siew Pheng Chan, Jeremyjones Robles, Viswanathan Mohan, Neale Cohen, Margaret McGill, Li-Nong Ji
Asia-Pacific Perspectives on the Role of Continuous Glucose Monitoring in Optimizing Diabetes Management. Journal of diabetes science and technology (2023)
Li-Nong Ji, Jinmiao Lu, Leili Gao, Xiaoguang Yan, Jifang Li, Zhifeng Cheng, Lili Zhang, Junhang Tian, Ping Li, Jie Bai, Daosheng Xie, Jiahong Zhao, Juping Ding, Qiang Yu, Tong Wang
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy. Diabetes, obesity & metabolism (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Xiao-Fei Ye, Chao-Ying Miao, Wei Zhang, Li-Nong Ji, Ji-Gwang Wang, null null
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry. Journal of clinical hypertension (Greenwich, Conn.) 25 (2) (2023)
Li-Nong Ji, Yingying Luo, Yong Mong Bee, Jun Xia, Khue Thy Nguyen, Weigang Zhao, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Soo Lim, Daisuke Yabe, Margaret McGill, Ketut Suastika, Xiaoying Li, Alice Pik-Shan Kong, Wei Chen, Zhan Zhao, Chenchen Xu, Marisa Deodat, Xiaomei Yao
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guideline. Journal of diabetes (2023)
Lee-Ling Lim, Eric S H Lau, Johnny T K Cheung, Siew Pheng Chan, Li-Nong Ji, Soo Lim, Sirinart Sirinvaravong, A G Unnikrishnan, Andrea On Yan Luk, Viviana Cortese, Alexandra Durocher, Juliana Chung Ngor Chan
Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register. Diabetes, obesity & metabolism (2022)
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David C Klonoff, David T Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jefferie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg D Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre Yves Benhamou, B Wayne Bequette, Thomas Blevins, Marc D Breton, Jessica R Castle, James Geoffrey Chase, Kong Y Chen, Pratik Choudhary, Mark A Clements, Kelly L Close, Curtiss B Cook, Thomas Danne, Francis J Doyle Iii, Andjela T Drincic, Kathleen M Dungan, Steven V Edelman, Niels Ejskjær, Juan C Espinoza, G Alexander Fleming, Gregory P Forlenza, Guido Freckmann, Rodolfo J Galindo, Ana Maria Gómez, Hanna A Gutow, Lutz Heinemann, Irl B Hirsch, Thanh Duc Hoang, Roman Hovorka, Johan H Jendle, Li-Nong Ji, Shashank R Joshi, Michael Joubert, Suneil K Koliwad, Rayhan A Lal, M Cecilia Lansang, Wei-An Andy Lee, Lalantha Leelarathna, Lawrence Alan Leiter, Marcus Lind, Michelle L Litchman, Julia Katharina Mader, Katherine M Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Nicolas Mathioudakis, Alexander Y Mayorov, Jordan Messler, Joshua D Miller, Viswanathan Mohan, James H Nichols, Kirsten Nørgaard, David Norman O'Neal, Francisco J Pasquel, Athena Philis-Tsimikas, Thomas R Pieber, Moshe Phillip, William H Polonsky, Pradipta R Ray, Gerry Rayman, Eun Jung Rhee, Steven J Russell, Viral N Shah, Jennifer L Sherr, Koji Sode, Elias K Spanakis, Deborah J Wake, Kayo Waki, Amisha Wallia, Melissa E Weinberg, Howard Wolpert, Eugene E Wright, Mihail Zilbermint, Boris P Kovatchev
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of diabetes science and technology (2022)
Vittal Hejjaji, Juan J Gorgojo-Martinez, Fengming Tang, Julia Blanco Garnelo, Andrew Cooper, Jesús Medina, Miren Sequera Mutiozabal, Kamlesh Khunti F MedSci, Antonio Nicolucci, Marina V Shestakova, Li-Nong Ji, Marília Brito Gomes, Hirotaka Watada, Jiten Vora, Ali O Malik, Mikhail Kosiborod, Suzanne V Arnold
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study. Diabetes, obesity & metabolism 24 (9) (2022)
Leili Gao, Zhifeng Cheng, Benli Su, Xiuhai Su, Weihong Song, Yushan Guo, Lin Liao, Xiaowen Chen, Jiarui Li, Xingrong Tan, Fangjiang Xu, Shuguang Pang, Kun Wang, Jun Ye, Yuan Wang, Lili Chen, Jingfang Sun, Li-Nong Ji
Efficacy and Safety of Janagliflozin as Add-on Therapy to Metformin in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Trial. Diabetes, obesity & metabolism (2022)
Stefan Pleus, Guido Freckmann, Sebastian Schauer, Lutz Heinemann, Ralph Ziegler, Li-Nong Ji, Viswanathan Mohan, Luis Eduardo P Calliari, Rolf Hinzmann
Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (5) (2022)
Tadej Battelino, Frank Brosius, Antonio Ceriello, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T Prashant Nedungadi, Lars Rydén, Helena W Rodbard, Li-Nong Ji, Wayne Huey-Herng Sheu, Eberhard Standl, Christopher G Parkin, Oliver Schnell
Guideline Development for Medical Device Technology: Issues for Consideration. Journal of diabetes science and technology (2022)
Suzanne V Arnold, Kamlesh Khunti, Fengming Tang, Hungta Chen, Antonio Nicolucci, Marília Brito Gomes, Li-Nong Ji, Marina V Shestakova, Hirotaka Watada, Andrew Cooper, Peter Fenici, Niklas Hammar, Jesús Medina, Mikhail Kosiborod, null null
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study. Endocrinology, diabetes & metabolism 5 (2) (2022)
Kamlesh Khunti F MedSci, Bernard Charbonnel, Andrew Cooper, Marília Brito Gomes, Li-Nong Ji, Paul Leigh, Antonio Nicolucci, Wolfgang Rathmann, Marina V Shestakova, Afrah Siddiqui, Fengming Tang, Hirotaka Watada, Hungta Chen, null null
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study. Diabetes, obesity & metabolism 23 (8) (2021)
Fabrice Bonnet, Hungta Chen, Andrew Cooper, Marília Brito Gomes, Li-Nong Ji, Paul Leigh, Larisa Ramirez, Marina V Shestakova, Iichiro Shimomura, Afrah Siddiqui, Fengming Tang, Jiten Vora, Hirotaka Watada, Kamlesh Khunti F MedSci
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study. Diabetes, obesity & metabolism 23 (10) (2021)
Kamlesh Khunti F MedSci, Bernard Charbonnel, Hungta Chen, David Z Cherney, Andrew Cooper, Peter Fenici, Marília Brito Gomes, Niklas Hammar, Hiddo J Lambers Heerspink, Li-Nong Ji, Jesús Medina, Antonio Nicolucci, Larissa Ramirez, Wolfgang Rathmann, Marina V Shestakova, Iichiro Shimomura, Fengming Tang, Hirotaka Watada, Mikhail Kosiborod, null null
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study. Diabetes, obesity & metabolism 23 (8) (2021)
Li-Nong Ji, Ling Li, Jianhua Ma, Xuefeng Li, Dongmei Li, Bangzhu Meng, Weiping Lu, Jiao Sun, Yanmei Liu, Gen Takayanagi, Yi Wang
Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double-blind, placebo-controlled study. Endocrinology, diabetes & metabolism 4 (2) (2021)
Chao-Ying Miao, Xiao-Fei Ye, Wei Zhang, Li-Nong Ji, Ji-Gwang Wang, null null
Association between dyslipidemia and antihypertensive and antidiabetic treatments in a China multicenter study. Journal of clinical hypertension (Greenwich, Conn.) 23 (7) (2021)
Li-Nong Ji, Xiaolin Dong, Yiming Li, Yufeng Li, Soo Lim, Ming Liu, Zu Ning, Søren Rasmussen, Trine Vang Skjøth, Guoyue Yuan, Freddy G Eliaschewitz
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial. Diabetes, obesity & metabolism 23 (2) (2021)
Philip D Home, Lawrence Blonde, Sanjay Kalra, Li-Nong Ji, Patricia Guyot, Claire Brulle-Wohlhueter, Erin Murray, Roshan Shah, Toby Sayre, Alka Shaunik
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis. Diabetes, obesity & metabolism 22 (11) (2020)
Li-Nong Ji, Hailong Wan, Binhong Wen, Xueying Wang, Junfen Wang, Rongwen Bian, Wuyan Pang, Jian Tian, Yan Wang, Fang Bian, Zhengnan Gao, Alex Condoleon, Wei Feng, Xia Zhang, Nan Cui
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII). Diabetes, obesity & metabolism 22 (5) (2020)
Krishna K Patel, Marília Brito Gomes, Bernard Charbonnel, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Li-Nong Ji, Kevin F Kennedy, Kamlesh Khunti F MedSci, Mikhail Naum Kosiborod, Stuart J Pocock, Marina V Shestakova, Iichiro Shimomura, Filip Surmont, Hirotaka Watada, Suzanne V Arnold
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study. Diabetes, obesity & metabolism 23 (1) (2020)
Chin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, Bien Matawaran, Wayne Huey Herng Sheu, Juliana Chung Ngor Chan, Ambrish Mithal, Andrea On Yan Luk, Ketut Suastika, Kun-Ho Yoon, Li-Nong Ji, Nguyen Huu Man, Carol Pollock
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations. Diabetes, obesity & metabolism 23 (2) (2020)
Wei Zhang, Chang-Yuan Liu, Li-Nong Ji, Ji-Gwang Wang, null null
Blood pressure and glucose control and the prevalence of albuminuria and left ventricular hypertrophy in patients with hypertension and diabetes. Journal of clinical hypertension (Greenwich, Conn.) 22 (2) (2020)
Xiaomei Zhang, Yujin Ma, Hong Chen, Ying Lou, Li-Nong Ji, Mingxing Xie
A pragmatic study of mid-mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real-world experience. Diabetes, obesity & metabolism 22 (8) (2020)
Li-Nong Ji, Juliana Chung Ngor Chan, Miao Yu, Kun-Ho Yoon, Sin Gon Kim, Sung Hee Choi, Chien-Ning Huang, Shih Te Tu, Chih-Yuan Wang, Päivi Maria Paldánius, Wayne Huey Herng Sheu
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective. Diabetes, obesity & metabolism 23 (1) (2020)
Puhong Zhang, Heng Zhang, Xian Li, Minyuan Chen, Du Wang, Li-Nong Ji
Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus. Endocrinology, diabetes & metabolism 3 (2) (2020)
Yu-Qing Zhang, Yong Li, Yu-Gang Dong, Yan-Hua Wu, Rui Bian, Ji-Hu Li, Li-Nong Ji
A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients. Journal of clinical hypertension (Greenwich, Conn.) 21 (11) (2019)
Chaicharn Deerochanawong, Siew P Chan, Bien J Matawaran, Wayne Huey Herng Sheu, Juliana Chan, Nguyen H Man, Ketut Suastika, Chin M Khoo, Kun-Ho Yoon, Andrea On Yan Luk, Ambrish Mithal, Li-Nong Ji
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations. Diabetes, obesity & metabolism 21 (11) (2019)
Li-Nong Ji, Yanmei Liu, Heng Miao, Yongli Xie, Ming Yang, Wei Wang, Yuting Mu, Ping Yan, Sharon Pan, Brett Lauring, Shu Liu, Susan Huyck, Yanping Qiu, Steven G Terra
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia. Diabetes, obesity & metabolism 21 (6) (2019)
Li-Nong Ji, Eun Seok Kang, XiaoLin Dong, Ling Li, GuoYue Yuan, Shuhua Shang, Elisabeth Niemoeller, null null
Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial. Diabetes, obesity & metabolism 22 (4) (2019)
Li-Nong Ji, Ningling Sun, Yunliang Zhang, Lihui Zhang, Sheng'ai Shen, Xueying Wang, Qiuyun Li, Luling Dong, Weidong Ren, Lin Qi, Yufeng Li, Shuang Yan, Wenli Cheng, Hongyu Kuang, Guangwei Li
Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open-label, randomized controlled clinical study. Diabetes, obesity & metabolism 22 (2) (2019)
Li-Nong Ji, Jing Liu, Jing Yang, Yufeng Li, Li Liang, Dalong Zhu, Quanmin Li, Tianrong Ma, Haiyan Xu, Yanlan Yang, Jiaoe Zeng, Bo Feng, Shen Qu, Yiming Li, Lizhen Ma, Shanshan Lin, Jianping Wang, Wei Li, Weihong Song, Xiaoxing Li, Yong Luo, Shugang Xi, Mei Lin, Yu Liu, Zerong Liang
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial. Diabetes, obesity & metabolism 20 (4) (2018)
Li-Nong Ji, Ling Li, Jian Kuang, Tao Yang, Dong-Jun Kim, Azidah A Kadir, Chien-Ning Huang, Douglas Lee
Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial. Diabetes, obesity & metabolism 19 (5) (2017)
Yingying Luo, Sanjoy K Paul, Xianghai Zhou, Cuiqing Chang, Wei Chen, Xiaohui Guo, Jinkui Yang, Li-Nong Ji, Hongyuan Wang
Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes. Journal of diabetes research 2017 (2017)
Kamlesh Khunti F MedSci, Thomas R Godec, Jesús Medina, Laura Garcia-Alvarez, Josh Hiller, Marilia B Gomes, Javier Cid-Ruzafa, Bernard Charbonnel, Peter Fenici, Niklas Hammar, Kiyoshi Hashigami, Mikhail Kosiborod, Antonio Nicolucci, Marina V Shestakova, Li-Nong Ji, Stuart Pocock
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany. Diabetes, obesity & metabolism 20 (2) (2017)
Rui Zhang, Yufeng Li, Simin Zhang, Xiaoling Cai, Xianghai Zhou, Li-Nong Ji
The Association of Retinopathy and Plasma Glucose and HbA1c: A Validation of Diabetes Diagnostic Criteria in a Chinese Population. Journal of diabetes research 2016 (2016)